Venture Certified
| 연구개발유형 | 2024-06-12 ~ 2027-06-11 | 20240612020004 | 2024-06-12 |
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.0B | 0.0B |
| Operating Profit | -4.7B | -0.4B | -0.0B |
| Net Profit | -4.6B | -0.4B | 0.0B |
| Total Assets | 17.7B | 1.7B | 2.0B |
| Total Liabilities | 0.2B | 0.1B | 0.0B |
| Total Equity | 17.6B | 1.6B | 2.0B |
Operating Loss: Op. profit -5B
2 Consecutive Years of Net Loss
- 0.0%
▼ 2158.5%
▼ 72.2%
▼ 135.7%
| Name | Position | Role |
|---|---|---|
| 오원택 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 서초구",
"ceo_name": "오원택",
"certificate": [
{
"cert_number": "20240612020004",
"changes": "",
"disclosure_date": "2024-06-12",
"first_cert_date": "2024-06-12",
"no": "1",
"type": "연구개발유형",
"valid_period": "2024-06-12 ~ 2027-06-11"
}
],
"company_name": "(주)알파메드",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 200000000,
"cost_of_sales": 0,
"current_assets": 185472000,
"current_liabilities": 165000,
"gross_profit": 0,
"net_income": 2039000,
"net_income_bs": 1999000,
"non_current_assets": 15000000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 2401000,
"operating_profit": -362000,
"revenue": 0,
"sga_expenses": 362000,
"total_assets": 200472000,
"total_equity": 200307000,
"total_liabilities": 165000
},
"2023": {
"capital_stock": 200000000,
"cost_of_sales": 0,
"current_assets": 87054000,
"current_liabilities": 10344000,
"gross_profit": 0,
"net_income": -37456000,
"net_income_bs": -37456000,
"non_current_assets": 86142000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 3891000,
"operating_profit": -41347000,
"revenue": 0,
"sga_expenses": 41347000,
"total_assets": 173196000,
"total_equity": 162852000,
"total_liabilities": 10344000
},
"2024": {
"capital_stock": 200000000,
"cost_of_sales": 0,
"current_assets": 1686520000,
"current_liabilities": 15715000,
"gross_profit": 0,
"net_income": -455186000,
"net_income_bs": -455186000,
"non_current_assets": 86142000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 15823000,
"operating_profit": -471009000,
"revenue": 0,
"sga_expenses": 471009000,
"total_assets": 1772662000,
"total_equity": 1756947000,
"total_liabilities": 15715000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "의약품 연구개발",
"phone": "02-466-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 6/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |